Studies have shown significant cardiovascular effects of exogenous apelin administration,
Introduction 55
The apelin peptide and its G-protein coupled receptor APJ constitute a signaling pathway 56 implicated in numerous cardiac and vascular functions. The APJ receptor was first cloned by 57 homology to other known G-protein coupled receptors (GPCRs) and the human APJ amino acid 58 sequence is 31% identical to that of the angiotensin II type-1A receptor (26). Apelin is the only 59 known ligand for APJ and is synthesized as a pre-pro-peptide consisting of 77 amino acids with 60 shorter biologically active forms including the 36, 17, 16, 13, and 12 amino acids encoded in the 61 C-terminal region (5, 35, 36) . While each of these isoforms have biological activity, the 
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The apelin-APJ pathway regulates systemic perfusion and has effects both on the heart 71 and the vasculature. Exogenous apelin is a potent activator of cardiac contractility when added 72 to isolated rat cardiomyocytes or intact heart preparations, as well as when administered in vivo 73 to rats or mice (3, 12, 34) . In the vasculature, apelin is a vasodilator in both the arterial and 74 venous circulations, and these effects appear to be mediated at least in part by nitric oxide (7, 75 14, 19, 36) . In heart failure models, apelin has a positive inotropic effect on failing myocardium 76 (4, 15) . We have previously reported that chronic infusion of apelin to mice increases cardiac 77 output without causing hypertrophy (3). These numerous studies have well characterized the 78 effects of exogenous apelin, but the role of endogenous apelin-APJ signaling is less clear.
Plasma apelin levels increase in early heart failure, but are diminished during functional 80 decompensation, suggesting that endogenous apelin may be secreted in an attempt to increase 81 contractility (6). Consistent with this hypothesis, we found that APJ is one of the most 82 differentially expressed genes in the human failing heart (6). Aside from these direct effects on 83 the heart and circulation, the apelin-APJ pathway has actions that suggest a beneficial role in 84 heart failure. There is evidence for apelin antagonism of vasopressin release, and we have 85 recently found that apelin signaling antagonizes the renin-angiotensin system in murine models 86 of atherosclerosis (8, 9) .
87
To understand the role of endogenous apelin-APJ signaling in cardiovascular 88 physiology, we created mice lacking either the ligand (apelin -/-) or the receptor (APJ -/-) of this 89 pathway. Here we report that both apelin -/-and APJ -/-mice have decreased basal cardiac 90 contractility at the whole animal level with a more dramatic decrement at the cellular level, 
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Magnetic resonance imaging
136
Male and female mice aged 14-18 weeks (apelin +/+ n=8; apelin -/-n=7) were scanned as 137 previously described (3). Briefly, the mice were anesthetized with 2% isoflurane with an 138 oxygen flow rate of 1 L/min. ECG leads were inserted subcutaneously and respiration was 139 monitored using a pneumatic pillow placed on the abdomen. The mouse body temperature 140 was monitored by a rectal probe and kept at 37º C by heated air. Magnetic resonance images 141 were acquired on a 4.7 T Oxford magnet controlled by a Varian Inova console (Varian, Palo
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Alto, CA). Image acquisition was gated to respiration and to the ECG R wave (SA Instruments,
143
Stony Brook, NY). Coronal and sagittal scout images were followed by six contiguous 1-mm-144 thick, short axis slices orthogonal to the interventricular septum. Nine cine frames were taken 145 at each slice level and were acquired through more than one cardiac cycle guaranteeing 
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Graded treadmill running
170
Male and female mice aged 10-14 weeks (apelin +/+ n=17; apelin -/-n=12 and APJ +/+ n=18; APJ -171 /-n=14) were placed into an a Simplex II metabolic rodent treadmill (Columbus Instruments,
172
Columbus, OH) which allows measurement of oxygen consumption (VO2) and carbon dioxide 173 production (VCO2) using a closed-chamber volumetric method of gas analysis. The respiratory 174 exchange ratio (RER) was calculated as the ratio of VCO2 to VO2. Calibration of the O2 and 176 CO2 -20.5% O2 -79% N2) and an offset gas (100% N2). Mice were subjected to a graded 177 exercise protocol similar to those previously described in our laboratory (10). Briefly, mice were 178 placed into the exercise chamber and allowed to equilibrate for 6 minutes. Treadmill activity 179 was initiated at 7.5 m/min at a 4º incline and was increased 2.5 m/min and 2º of incline every 3 180 minutes until the mice showed signs of exhaustion. Mice were then allowed to recover in the 181 chamber for 15 minutes. This exercise protocol was performed only once on each mouse so that 182 conditioning was not a confounder. 
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(Hyclone, Logan, UT)) was added and the cell suspension was collected in a 15ml tube and 199 centrifuged at 30g for 3 minutes. Myocytes were resuspended in stop buffer containing 100 mM
200
CaCl2, allowed to rest for 2 minutes, and then centrifuged at 30g for 3 minutes using a Sorvall RT6000B benchtop centrifuge. These steps were repeated using stop buffer with increasing 
Results 250
Apelin null mice show normal physiological development
251
Apelin null mice were generated using a construct that replaced the start codon and signal 
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Heterozygous APJ +/-animals were viable and fertile, however the litter size for these 272 animals was small, and the majority of pups failed to survive, due at least in part to poor 273 mothering behavior. This phenotypic trait was even more pronounced in the homozygous knockout mothers. This problem was ameliorated by fostering the pups onto an outbred CD1 
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Since apelin affects vascular resistance as well as cardiac contractility, it is important to measure 300 intact heart function in a way that is not as affected by changes in vascular loading conditions.
301
Pressure volume relationships are considered the gold standard for measuring load 302 independent contractility. Therefore, we performed pressure volume loops and analyzed 303 various regression parameters of systolic contractility including the end systolic pressure 304 volume relationship (ESPVR), preload recruitable stroke work (PRSW), and maximal elastance 305 (Emax). We found that apelin null mice had significantly lower ESPVR ( Figure 3A 
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Since motivation can be a significant confounder in exercise testing, maximum exercise was 321 defined metabolically when mice achieved a respiratory exchange ratio (RER) greater than 1.0.
322
At this point, CO 2 production begins to exceed O 2 consumption. Additionally, exercise 
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To begin to determine a mechanism for these changes, we assessed calcium fluorescence 
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The most striking finding in our data came from the in vitro cardiomyocyte studies.
379
Using isolated single left ventricular myocytes from apelin -/-and APJ -/-mice, we observed 380 impaired sarcomeric function with no change in baseline sarcomeric length. We also noted changes in the rate of sarcomere contraction and relaxation, suggesting overall that the apelin- 
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We interpret these data in isolated cardiomyocytes to suggest an autocrine apelin-APJ 399 pathway may be activated in the myocardium under conditions of cardiovascular stress. 
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It is important to note that the cardiovascular phenotype seen in this study differed 411 between the apelin -/-and APJ -/-mice. Currently, apelin is considered to be the only ligand for 412 APJ, and APJ to be the only receptor for apelin. One would expect, therefore, that the 413 phenotype generated by functional deletion of apelin and APJ genes should be very similar if 414 not identical. The most striking phenotypic difference is the embryonic developmental defect in 415 the APJ, but not in the apelin, null animals. This is not due to background strain differences, as 
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Male agouti offspring of chimeric founder mice were evaluated by Southern blot with an apelin 608 genomic probe. The wildtype allele (+) migrates at 12 kb, and the targeted allele (-) at 17 kb.
609
There is only one allele for apelin in these male mice since apelin is on the X chromosome. (C)
610
A construct was created with loxP recombination sites flanking the APJ gene, and a loxP 
